Gå offline med appen Player FM !
Neerja Bhatla on a new quadrivalent HPV vaccine
Manage episode 386539289 series 2829082
Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00480-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
208 episoder
Manage episode 386539289 series 2829082
Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00480-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
208 episoder
すべてのエピソード
×
1 Professor Amar U. Kishan on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA) 7:33

1 Ariana Znaor on cancer surveillance in the Eastern Mediterranean region 20:03

1 Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials 18:03

1 Yannick Romero on the changing landscape of national cancer control plans 24:40

1 M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries 22:15

1 Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma 15:07

1 Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination 17:21

1 May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics 40:45

1 Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02) 13:22

1 Emmy Boerrigter on dose selection of novel anticancer drugs 11:41

1 Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations 36:56

1 Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment 24:08

1 James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean 35:05

1 Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials 11:22

1 Maria Kyrgiou on innovations in gynaecological cancers and global disparities 25:42
Välkommen till Player FM
Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.